Fr. 240.00

Japanese Pharmaceutical Industry - Its Evolution and Current Challenges

English · Hardback

Shipping usually within 1 to 3 weeks (not available at short notice)

Description

Read more

Zusatztext 'The Japanese Pharmaceutical Industry is an ambitious! broad-ranging analysis of the postwar history of an industry whose eight per cent share of Japanese manufacturing understates its significance in terms of health and as a barometer for science-based innovation.' - Robert Kneller! University of Tokyo; Journal of Japanese Studies! 2013. Informationen zum Autor Maki Umemura is a lecturer in Japanese studies at Cardiff Business School, Cardiff University, UK. Klappentext Charting the development of the industry from post-war devastation, through good recovery in the 1960s, and then up to the present, the book explores why Japan, despite being a world leader in many high technology industries, is only a minor player in the global pharmaceutical industry. Zusammenfassung Charting the development of the industry from post-war devastation, through good recovery in the 1960s, and then up to the present, the book explores why Japan, despite being a world leader in many high technology industries, is only a minor player in the global pharmaceutical industry. Inhaltsverzeichnis 1. Introduction: Why didn’t Japan become a global leader in pharmaceuticals? 2. A historical overview of Japan’s pharmaceutical industry 3. Developing a modern industry: The antibiotics sector 4. What went wrong? The anticancer drug sector 5. Conclusion: Reconsidering Japan’s business in pharmaceuticals

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.